Inbiomotion's MAF Test® selects breast cancer patients

/PRNewswire/ -- Inbiomotion SL, a company developing a unique single-gene-based biomarker for the personalized adjuvant treatment of early-stage (stage I-III)...

Related Keywords

Spain , Barcelona , Comunidad Autonoma De Cataluna , Peterc Lucas , Antonioc Wolff , Jean Mairet , Alexander Paterson , Eleftheriosp Mamounas , Norman Wolmark , Juan Carlos Tercero , Luis Baez Diaz , Karenm King , Stewartj Anderson , Adam Brufsky , Roger Gomis , Miguel Sampayo , Alexander Hg Paterson , Rogerr Gomis , Melanie Finnigan , Louis Fehrenbacher , Research Professor , University Of Calgary , Journal Of The National Cancer Institute , Department Of Oncology , National Cancer Institute , Emeritus Clinical Professor , Executive Chairman , Professor Emeritus , Adjuvant Clodronate Outcomes , Early Stage Breast Cancer , Potential Impact , Thomas Lad , Inbiomotion ,